Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Category 3

Growth (3)

GH Therapy in Prepubertal Children: Results After 4 Years
aUniversity of Medicine and Pharmacy, Iasi, Romania; bRomanian Academy of Medical Sciences, Iasi, Romania
hrp0082p3-d2-849
A Follow-up Study up to Adult Height of the Patients Included in the Phase iii Clinical Trial with the Biosimilar Human Recombinant GH (omnitrope®) on the Treatment of Spanish Children with GH Deficit
aHospital General Granolers, Barcelona, Spain; bHospital Universitario Carlos Haya, Malaga, Spain; cHospital Ciudad de Jaén, Jaen, Spain; dCorporación Sanitaria Parc Tauli, Barcelona, Spain; eHospital San Cecilio, Granada, Spain; fHospital Universitario Miguel Servet, Zaragoza, Spain; gHospital Sacrat Cor, Barcelona, Spain; hHospital Universitario de Salamanca, Salamanca, Spain; iHospital San Joan de Deu, Barcelona, Spain; jHospital Universitario Arnau Villanova, Lérida, Spain; kHospital Nuestra Sra Valme, Sevilla, Spain; lSandoz Farmacéutica, Madrid, Spain
hrp0082p3-d2-850
Growth pattern of the nigerian child compared to international references
aDepartment of Paediatrics and Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria; bDepartment of Paediatrics, Federal Teaching Hospital, Abakaliki, Ebonyi State, Nigeria; cDepartment of Paediatrics, Federal Medical Centre, Gombe, Gombe, Nigeria; dDepartment of Paediatrics, Sandwell and West Birmingham NHS Trust, West Bromwich, UK
hrp0082p3-d2-851
Evaluation of Potential Waste of GH Across Available GH Pen Devices and an Electronic GH Delivery Device
aEMD Serono, Inc., Rockland, Massachusetts, USA; bHealth Services Consulting Corporation, Boxborough, Massachusetts, USA
hrp0082p3-d2-852
Switching From the Original to the Biosimilar Recombinant Human GH - Omnitrope[reg]: an Experience of a Single Paediatric Centre in Spain
aHospital Universitario Virgen del Rocío, Sevilla, Spain; bSandoz Farmacéutica, Madrid, Spain
hrp0082p3-d2-853
Descriptive Analysis of Medication Adherence for Patients Treated with GH Therapy
aCompetitive Health Analytics – A Humana Company, Louisville, Kentucky, USA; bEMD Serono, Inc., Rockland, Massachusetts, USA; cFormerly EMD Serono, Inc., Rockland, Massachusetts, USA
hrp0082p3-d2-854
Effect of Cyanotic and Acyanotic Congenital Heart Disease on Placental and Birth Size
aDepartment of Pediatrics Hamad Medical Center, Doha, Qatar; bNeonatal ICU Hamad Medical Center, Doha, Qatar
hrp0082p3-d2-855
Differences in Personality of Monozygotic Twins can be Predicted by Difference in Birth Weight in Teen Monozygotic Twins
aPediatric Endocrinology Division, Children’s Hospital, University of Bonn, Bonn, Germany; bDepartment of Neonatology, Children’s Hospital, University of Bonn, Bonn, Germany
hrp0082p3-d2-857
The Growth Speed of Late Pretem Infants Aged 1 Year
Department of Primary Child Health Care, Children’s Hospital, Chongqing Medical University, Chongqing, China
hrp0082p3-d2-858
Response of GH Therapy in Six Children with Achondroplasia
aDepartment of Pediatrics, Keimyung University School of Medicine, Daegu, Republic of Korea; bDepartment of Radiology, Keimyung University School of Medicine, Daegu, Republic of Korea
hrp0082p3-d2-859
Clinical Expression of Familial Williams-Beuren Syndrome in a Turkish Family
aDepartment of Pediatric Endocrinology, Akdeniz University School of Medicine, Antalya, Turkey; bDepartment of Pediatric Genetics, Akdeniz University School of Medicine, Antalya, Turkey; cDepartment of Medical Biology and Genetics, Akdeniz University School of Medicine, Antalya, Turkey
hrp0082p3-d2-860
Abstract unavailable
hrp0082p3-d2-861